| Nome |
# |
|
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair, file 12e43767-a2b5-447e-892d-246153f464b1
|
1.006
|
|
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score, file dfe4d22b-cd61-bb0a-e053-d805fe0a78d9
|
809
|
|
Effectiveness of MitraClip Therapy in Patients with Refractory Heart Failure, file dfe4d22b-c599-bb0a-e053-d805fe0a78d9
|
784
|
|
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary, file dfe4d22c-2e06-bb0a-e053-d805fe0a78d9
|
777
|
|
The year in cardiology 2017: coronary interventions, file dfe4d22b-ea4f-bb0a-e053-d805fe0a78d9
|
765
|
|
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture, file dfe4d22a-6ff4-bb0a-e053-d805fe0a78d9
|
176
|
|
Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold, file dfe4d22a-78c7-bb0a-e053-d805fe0a78d9
|
173
|
|
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2, file dfe4d22c-24f7-bb0a-e053-d805fe0a78d9
|
109
|
|
Terapia antitrombotica nei pazienti sottoposti a impianto transcatetere di valvola aortica: Alla ricerca del Santo Graal [Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: The quest for the Holy Grail], file dfe4d22b-5608-bb0a-e053-d805fe0a78d9
|
80
|
|
Eroded versus Ruptured Plaques at the Culprit Site of ST-Elevation Myocardial Infarction: in-vivo Pathophysiological Features and Response to Primary Percutaneous Coronary Intervention, file dfe4d22c-3c51-bb0a-e053-d805fe0a78d9
|
58
|
|
Ventricular Arrhythmias in Aortic Valve Stenosis Before and After Transcatheter Aortic Valve Implantation, file dfe4d22a-7f3d-bb0a-e053-d805fe0a78d9
|
51
|
|
Procedural management of patients with advanced heart failure undergoing MitraClip implantation (from the GRASP registry), file dfe4d22b-7e5f-bb0a-e053-d805fe0a78d9
|
51
|
|
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the
GHOST-EU and XIENCE V USA Registries, file dfe4d22b-dd29-bb0a-e053-d805fe0a78d9
|
44
|
|
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death:
The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), file dfe4d22c-2a17-bb0a-e053-d805fe0a78d9
|
44
|
|
Bioresorbable Scaffolds in Coronary Intervention: Unmet Needs and Evolution, file dfe4d22c-939d-bb0a-e053-d805fe0a78d9
|
44
|
|
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients., file dfe4d22a-ef5d-bb0a-e053-d805fe0a78d9
|
43
|
|
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry., file dfe4d22b-daa7-bb0a-e053-d805fe0a78d9
|
42
|
|
MitraClip Implantation for the Treatment of New-Onset Systolic Anterior Motion of the Mitral Valve After Transcatheter Aortic Valve Replacement, file dfe4d22b-7e6e-bb0a-e053-d805fe0a78d9
|
41
|
|
Pretreatment with Antiplatelet Drugs in Invasively Managed Patients With Coronary Artery Disease in the Contemporary Era: Review of the Evidence and Practice Guidelines, file dfe4d22a-c9be-bb0a-e053-d805fe0a78d9
|
36
|
|
Radial access reduces mortality in patients with acute coronary syndromes. Results from an updated trial sequential analysis of randomized trials, file dfe4d22a-eb8d-bb0a-e053-d805fe0a78d9
|
35
|
|
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients, file dfe4d22b-e534-bb0a-e053-d805fe0a78d9
|
31
|
|
Very Late Outcomes of Drug-Eluting Stents: The "Catch-Down" Phenomenon, file dfe4d22c-02a4-bb0a-e053-d805fe0a78d9
|
30
|
|
Bioresorbable scaffolds for calcified lesions: not a free lunch!, file dfe4d22b-07b5-bb0a-e053-d805fe0a78d9
|
27
|
|
Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions, file b774620c-1d7a-41c4-ae3b-d9939fac3bda
|
24
|
|
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement, file dfe4d22e-8c1a-bb0a-e053-d805fe0a78d9
|
21
|
|
Operator volume and mortality in percutaneous coronary intervention: a call for better competency metrics, file dfe4d22c-0bf6-bb0a-e053-d805fe0a78d9
|
19
|
|
Bioresorbable everolimus-eluting vascular scaffold for long coronary lesions: a subanalysis of the international, multi-center GHOST-EU registry, file dfe4d22b-7e5e-bb0a-e053-d805fe0a78d9
|
18
|
|
Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry, file dfe4d22b-a5e2-bb0a-e053-d805fe0a78d9
|
18
|
|
Joint EACVI HIT / EAPCI young survey / ESC CoT survey: Training and education for
“multimodality imaging in structural interventions”: the rise of a new sub-specialty?, file dfe4d22c-3a9c-bb0a-e053-d805fe0a78d9
|
17
|
|
Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), file dfe4d22b-f769-bb0a-e053-d805fe0a78d9
|
16
|
|
Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk, file dfe4d22d-d4cb-bb0a-e053-d805fe0a78d9
|
16
|
|
Statistical primer: methodology and reporting of meta-analyses, file dfe4d22b-e237-bb0a-e053-d805fe0a78d9
|
15
|
|
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation), file dfe4d22b-7e5d-bb0a-e053-d805fe0a78d9
|
14
|
|
The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease, file dfe4d22b-b249-bb0a-e053-d805fe0a78d9
|
14
|
|
Standardised Definitions of Structural Deterioration and Valve Failure in Assessing Long-Term Durability of Transcatheter and Surgical Aortic Bioprosthetic Valves: A Consensus Statement from The European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), file dfe4d22d-b926-bb0a-e053-d805fe0a78d9
|
14
|
|
Moderate and severe preoperative chronic kidney disease worsen clinical outcomes after transcatheter aortic valve implantation: meta-analysis of 4992 patients., file dfe4d229-40c3-bb0a-e053-d805fe0a78d9
|
13
|
|
Revisiting the Network of Drug-eluting Stent Trials: Bioresorbable Scaffolds Enter the Arena, file dfe4d22b-148b-bb0a-e053-d805fe0a78d9
|
13
|
|
Assessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME Era, file dfe4d22b-8f9b-bb0a-e053-d805fe0a78d9
|
13
|
|
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality?, file dfe4d22b-18e0-bb0a-e053-d805fe0a78d9
|
12
|
|
New-onset coronary aneurism and late-acquired incomplete scaffold apposition after full polymer jacket of a chronic total occlusion with bioresorbable scaffolds, file dfe4d22b-5e4c-bb0a-e053-d805fe0a78d9
|
12
|
|
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry, file dfe4d22b-612a-bb0a-e053-d805fe0a78d9
|
12
|
|
Prevention of Acute Kidney Injury with the RenalGuard System in patients undergoing Transcatheter Aortic Valve Implantation: The PROTECT-TAVI trial, file dfe4d22b-d0b1-bb0a-e053-d805fe0a78d9
|
12
|
|
Triple Therapy for Atrial Fibrillation and Acute Coronary Syndromes With or Without Percutaneous Coronary Intervention: Don't drop aspirin just yet, file dfe4d22a-6f8d-bb0a-e053-d805fe0a78d9
|
11
|
|
Embolization of fractured bioresorbable scaffold struts: insights from 2- and 3-dimensional optical coherence tomography, file dfe4d22a-7594-bb0a-e053-d805fe0a78d9
|
11
|
|
Reply: plaque rupture in stable coronary artery disease, file dfe4d22a-80fe-bb0a-e053-d805fe0a78d9
|
11
|
|
Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement, file dfe4d22b-911f-bb0a-e053-d805fe0a78d9
|
11
|
|
Triaging patients with left main disease after the EXCEL and NOBLE trials: The everlasting saga of coronary artery bypass grafting and percutaneous coronary intervention, file dfe4d22c-4edb-bb0a-e053-d805fe0a78d9
|
11
|
|
Bivalirudin For Acute Coronary Syndromes: Premises, Promises and Doubts, file dfe4d22a-89c2-bb0a-e053-d805fe0a78d9
|
10
|
|
Optical coherence tomography assessment of late intra-scaffold dissection: a new challenge of bioresorbable scaffolds, file dfe4d22b-b48c-bb0a-e053-d805fe0a78d9
|
10
|
|
Update on clinical evidence (Part II): a summary of the main post market studies, file dfe4d22b-e099-bb0a-e053-d805fe0a78d9
|
10
|
|
Angiographic or Functional Success?: Rethinking the Goal of Percutaneous Coronary Intervention, file dfe4d22c-24f6-bb0a-e053-d805fe0a78d9
|
10
|
|
Heparin versus bivalirudin for percutaneous coronary intervention: Has the debate come to an end?, file dfe4d22c-3e02-bb0a-e053-d805fe0a78d9
|
10
|
|
Overlapping meta-analyses of bioresorbable vascular scaffolds versus everolimus-eluting stents: bringing clarity or confusion?, file dfe4d22a-89a0-bb0a-e053-d805fe0a78d9
|
9
|
|
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery, file dfe4d22a-f65d-bb0a-e053-d805fe0a78d9
|
9
|
|
Is the metallic stent a safe treatment for bioresorbable scaffold failure? Insights from optical coherence tomography, file dfe4d22b-13b9-bb0a-e053-d805fe0a78d9
|
9
|
|
Clinical, Angiographic, Functional and Imaging Outcomes 12 Months after Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds in Acute Coronary Syndromes, file dfe4d22b-e37a-bb0a-e053-d805fe0a78d9
|
9
|
|
Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA), file a86aff4b-1c06-45b2-8578-2031e84e80d8
|
8
|
|
Mini-crush versus T-provisional techniques in bifurcation lesions: clinical and angiographic long term outcome after implantation of drug–eluting stents, file dfe4d227-06d9-bb0a-e053-d805fe0a78d9
|
8
|
|
Reply: Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome, file dfe4d22a-bc0f-bb0a-e053-d805fe0a78d9
|
8
|
|
Longitudinal elongation, axial compression, and effects on strut geometry of bioresorbable vascular scaffolds: insights from 2- and 3-dimensional optical coherence tomography imaging, file dfe4d22a-e183-bb0a-e053-d805fe0a78d9
|
8
|
|
Revisiting Sex Equality With Transcatheter Aortic Valve Replacement Outcomes: A Collaborative, Patient-Level Meta-Analysis of 11,310 Patients, file dfe4d22b-7ac4-bb0a-e053-d805fe0a78d9
|
8
|
|
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device Iterations, file dfe4d22b-a891-bb0a-e053-d805fe0a78d9
|
8
|
|
Optimal P2Y12 inhibitor for primary PCI in STEMI: Network meta-analysis in the data-fre zone. Do you believe in magic?, file dfe4d22c-41c2-bb0a-e053-d805fe0a78d9
|
8
|
|
Temporal course of vascular healing and neoatherosclerosis after implantation of durable- or biodegradable-polymer drug-eluting stents, file dfe4d22d-c37e-bb0a-e053-d805fe0a78d9
|
8
|
|
Reference Renal Artery Diameter Is a Stronger Predictor of Contrast-Induced Nephropathy than Chronic Kidney Disease in Patients with High Cardiovascular Risk, file dfe4d229-ef47-bb0a-e053-d805fe0a78d9
|
7
|
|
Current Status and Clinical Development of Transcatheter Approaches for Severe Mitral Regurgitation, file dfe4d22a-d1e9-bb0a-e053-d805fe0a78d9
|
7
|
|
Fate of Coronary Chronic Total Occlusion Recanalization via Subintimal Tracking With Bioresorbable Vascular Scaffolds: A Temporary Cage for a Permanent New Lumen?, file dfe4d22b-558b-bb0a-e053-d805fe0a78d9
|
7
|
|
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), file dfe4d22b-f8a3-bb0a-e053-d805fe0a78d9
|
7
|
|
Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus, file dfe4d22c-0292-bb0a-e053-d805fe0a78d9
|
7
|
|
Impact of Culprit Plaque and Atherothrombotic Components on Incomplete Stent Apposition in Patients with ST-elevation Myocardial Infarction Treated with Everolimus-Eluting Stents: an OCTAVIA sub-study, file dfe4d22c-0294-bb0a-e053-d805fe0a78d9
|
7
|
|
Aspirin Desensitization in Patients with Coronary Artery Disease: Results of a Multicenter ADAPTED Registry, file cfb035bb-6a7f-4281-b0c2-4cc6e668607a
|
6
|
|
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice, file d2194fee-5a2b-4661-97c0-a7419a9edcf2
|
6
|
|
Atrial and ventricular function in thalassemic patients with supraventricular arrhythmias, file 5b933e5f-438d-41ad-b813-d1d204cd837d
|
5
|
|
Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis: SCOPE 2 Randomized Clinical Trial, file 8612fa32-74cb-4440-8a20-adc949936ce1
|
5
|
|
Pooling the Evidence at the Patient Level: End of the Bivalirudin Saga?, file a7704d11-7648-473b-9de0-745dbadb006f
|
5
|
|
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes, file ab8fd36b-888e-48ae-9887-b0dd4ad43e7f
|
5
|
|
Early and Midterm Outcomes of Bioresorbable Scaffolds for Ostial Coronary Lesions: Insights from the GHOST-EU Registry, file dfe4d22b-8c39-bb0a-e053-d805fe0a78d9
|
5
|
|
Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence from a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients, file dfe4d22b-a2ab-bb0a-e053-d805fe0a78d9
|
5
|
|
Prevalence and morphological changes of carotid kinking and coiling in growth: an echo-color Doppler study of 2856 subjects between aged 0 to 96 years, file 02450010-66f0-4eff-a67d-4155d4cf80be
|
4
|
|
2021 ESC/EACTS Guidelines for the management of valvular heart disease, file 1507293c-1b87-4213-8fa6-eb53af52bfcc
|
4
|
|
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group, file c01bf017-8568-42d0-bfcd-c988b7f91d28
|
4
|
|
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions, file dfe4d22e-3616-bb0a-e053-d805fe0a78d9
|
4
|
|
Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel, file 05a5bce8-9204-4502-9f9d-8d6b1d56cff1
|
3
|
|
Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel: The ABCD-GENE Score, file 390712d8-3409-4709-8f59-356b2eb985ea
|
3
|
|
Cardiovascular Magnetic Resonance for the Assessment of Patients undergoing Transcatheter Aortic Valve Implantation: A Pilot Study, file c41b2a33-e16f-4f8a-8305-3253d34d76f0
|
3
|
|
Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial, file c649fba5-1dd8-4756-bc0e-b2c3b4a50cc4
|
3
|
|
Relationship between early atrial and ventricular dysfuncion and supraventricular arrhytmias in Thalassemia Major. A Color Doppler Imaging Study, file dfe4d227-4374-bb0a-e053-d805fe0a78d9
|
3
|
|
Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting, file dfe4d227-7d0d-bb0a-e053-d805fe0a78d9
|
3
|
|
Incidence and Potential Mechanism of Resolved, Persistent and Newly Acquired Malapposition 3 days after Implantation of Self-expanding or Balloon-expandable Stent in STEMI population: insights from Optical Coherence Tomography in the Apposition II study, file dfe4d22b-7a49-bb0a-e053-d805fe0a78d9
|
3
|
|
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment, file dfe4d22b-8414-bb0a-e053-d805fe0a78d9
|
3
|
|
Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry., file dfe4d22b-89f3-bb0a-e053-d805fe0a78d9
|
3
|
|
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective., file dfe4d22b-8a9c-bb0a-e053-d805fe0a78d9
|
3
|
|
EFFETTI FARMACODINAMICI DI DIFFERENTI REGIMI DI SOMMINISTRAZIONE DELL'ASPIRINA IN PAZIENTI CON DIABETE MELLITO DI TIPO II E CARDIOPATIA ISCHEMICA, file 1ba29a3c-8a98-4c91-97ec-e39d77bf91df
|
2
|
|
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity., file dfe4d227-1fe1-bb0a-e053-d805fe0a78d9
|
2
|
|
Effect size of ticagrelor over clopidogrel in the Platelet Inhibition and Patient Outcomes (PLATO) trial: from statistics to clinical judgment, file dfe4d227-2305-bb0a-e053-d805fe0a78d9
|
2
|
|
A focused update on emerging prognostic determinants in distal left main percutaneous coronary intervention, file dfe4d227-3a14-bb0a-e053-d805fe0a78d9
|
2
|
|
Renal artery diameter: a “new” parameter beyond an old disease - the renal artery stenosis, file dfe4d227-4e9f-bb0a-e053-d805fe0a78d9
|
2
|
|
Long-term clinical and echocardiographic outcomes of Mitraclip therapy in patients nonresponders to cardiac resynchronization, file dfe4d229-b799-bb0a-e053-d805fe0a78d9
|
2
|
|
Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug eluting stents for percutaneous treatment of chronic total coronary occlusions: technical and procedural outcomes from the GHOST-CTO registry, file dfe4d22b-13b8-bb0a-e053-d805fe0a78d9
|
2
|
|
Transcatheter aortic valve implantation in 2017: state of the art, file dfe4d22b-60fd-bb0a-e053-d805fe0a78d9
|
2
|
| Totale |
5.900 |